Comedo Carcinoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: CMD001 MIFTS: 31	Comedo Carcinoma Categories: Cancer diseases
Genes Variations Tissues Related diseases Publications Pathways Drugs Download Expand all tables

Sources

Aliases & Classifications for Comedo Carcinoma

MalaCards integrated aliases for Comedo Carcinoma:

Name: Comedo Carcinoma ¹² ¹⁵

Comedocarcinoma ¹² ⁷³

High Grade Ductal Breast Carcinoma in Situ ⁷³

Classifications:

MalaCards categories:
Global: Cancer diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:5670

NCIt ⁵⁰ C4188

SNOMED-CT ⁶⁸ 189709000 36425007

UMLS ⁷³ C0334370 C1334002

Sources

Summaries for Comedo Carcinoma

Disease Ontology : ¹² A carcinoma that is in situ.

MalaCards based summary : Comedo Carcinoma, also known as comedocarcinoma, is related to leigh syndrome with leukodystrophy and glassy cell carcinoma of the cervix. An important gene associated with Comedo Carcinoma is ERBB2 (Erb-B2 Receptor Tyrosine Kinase 2), and among its related pathways/superpathways are Signaling by ERBB4 and Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors. The drugs Tamoxifen and Selective Estrogen Receptor Modulators have been mentioned in the context of this disorder. Affiliated tissues include breast and bone, and related phenotypes are shRNA abundance <= 50% and behavior/neurological

Wikipedia : ⁷⁶ Comedocarcinoma is one kind of breast cancer which is most commonly very early-stage which demonstrates... more...

Sources

Related Diseases for Comedo Carcinoma

Diseases related to Comedo Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 40)

#	Related Disease	Score	Top Affiliating Genes
1	leigh syndrome with leukodystrophy	10.0	NDUFS3 NDUFS4
2	glassy cell carcinoma of the cervix	10.0	ERBB2 ESR1
3	breast medullary carcinoma	10.0	ERBB2 ESR1
4	breast scirrhous carcinoma	10.0	ERBB2 ESR1
5	progesterone-receptor positive breast cancer	10.0	ERBB2 ESR1
6	oncocytic breast carcinoma	10.0	ERBB2 ESR1
7	apocrine adenocarcinoma	10.0	ERBB2 ESR1
8	breast adenoid cystic carcinoma	10.0	ERBB2 ESR1
9	uterine corpus cancer	10.0	ERBB2 ESR1
10	luminal breast carcinoma	10.0	ERBB2 ESR1
11	breast benign neoplasm	10.0	ERBB2 ESR1
12	thoracic benign neoplasm	9.9	ERBB2 ESR1
13	lobular neoplasia	9.9	ERBB2 ESR1
14	inflammatory breast carcinoma	9.9	ERBB2 ESR1
15	mixed cell type cancer	9.9	ERBB2 ESR1
16	lipid-rich carcinoma	9.9	ERBB2 ESR1
17	hidradenocarcinoma	9.9	ERBB2 ESR1
18	mammary paget's disease	9.9	ERBB2 ESR1
19	bilateral breast cancer	9.9	ERBB2 ESR1
20	tubular adenocarcinoma	9.9	ERBB2 ESR1
21	breast papillary carcinoma	9.9	ERBB2 ESR1
22	pre-malignant neoplasm	9.9	ERBB2 ESR1
23	fallopian tube carcinoma	9.9	ERBB2 ESR1
24	sweat gland cancer	9.9	ERBB2 ESR1
25	estrogen-receptor negative breast cancer	9.8	ERBB2 ESR1
26	in situ carcinoma	9.8	ERBB2 ESR1
27	breast fibroadenoma	9.8	ERBB2 ESR1
28	ovary epithelial cancer	9.8	ERBB2 ESR1
29	breast carcinoma in situ	9.8	ERBB2 ESR1
30	female breast cancer	9.8	ERBB2 ESR1
31	cervical adenocarcinoma	9.8	ERBB2 ESR1
32	estrogen-receptor positive breast cancer	9.7	ERBB2 ESR1
33	endometrial adenocarcinoma	9.7	ERBB2 ESR1
34	sporadic breast cancer	9.7	ERBB2 ESR1
35	ductal carcinoma in situ	9.7	ERBB2 ESR1
36	female reproductive organ cancer	9.6	ERBB2 ESR1
37	breast disease	9.6	ERBB2 ESR1
38	cell type cancer	9.5	ERBB2 ESR1
39	breast ductal carcinoma	9.4	ERBB2 ESR1
40	breast adenocarcinoma	9.1	ERBB2 ESR1

Graphical network of the top 20 diseases related to Comedo Carcinoma:

Sources

Symptoms & Phenotypes for Comedo Carcinoma

GenomeRNAi Phenotypes related to Comedo Carcinoma according to GeneCards Suite gene sharing:

²⁶

#	Description	GenomeRNAi Source Accession	Score	Top Affiliating Genes
1	shRNA abundance <= 50%	GR00343-S	9.02	ERBB2 ESR1 HNRNPA1 NDUFS3 NDUFS4

MGI Mouse Phenotypes related to Comedo Carcinoma:

⁴⁶

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	behavior/neurological	MP:0005386	9.02	ERBB2 ESR1 HNMT NDUFS3 NDUFS4

Sources

Drugs & Therapeutics for Comedo Carcinoma

Drugs for Comedo Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 11)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Tamoxifen

Approved

Phase 3

10540-29-1

2733526

Synonyms:

(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene

(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine

(Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine

(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine

(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine

(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC)

(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE

(Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine

,citrate

10540-29-1

1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-Para-b-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-Para-β-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-P-b-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-P-β-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1ya4

2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine

2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine

54965-24-1 (citrate)

AC1MBZ3R

apo-Tamox

Apo-Tamox

BIDD:ER0008

BIDD:GT0009

BIDD:PXR0003

BPBio1_000278

BRD-K93754473-001-02-9

BRD-K93754473-048-05-3

BSPBio_000252

BSPBio_001150

BSPBio_001982

C07108

C26H29NO

CCRIS 3275

CHEBI:41774

CHEMBL83

CID2733526

Citofen

Citrate, tamoxifen

cMAP_000044

Crisafeno

D08559

DB00675

Diemon

EINECS 234-118-0

Gen-tamoxifen

Gen-Tamoxifen

HMS1362J11

HMS1792J11

HMS1990J11

HMS2090N08

HSDB 6782

ICI 47699

ICI-46,474

ICI-47699

IDI1_000258

IDI1_002170

Istubol

Kessar

L024126

Lopac0_001203

LS-393

MLS001332535

MLS001332536

MolPort-003-850-384

NCGC00024928-01

NCGC00024928-03

NCGC00024928-04

NCGC00024928-05

NCGC00024928-07

NCGC00024928-08

NCGC00024928-09

NCGC00024928-12

nchembio.140-comp7

nchembio.76-comp1

nchembio732-comp3

Noltam

Nolvadex

Nolvadex-D

Nourytam

Novaldex

Novo-Tamoxifen

NSC727681

Oncomox

Pms-Tamoxifen

PMS-Tamoxifen

Prestwick2_000146

Prestwick3_000146

QTL1_000079

Retaxim

Savient brand OF tamoxifen citrate

SMR000059172

Soltamox

Spectrum5_001417

Spectrum5_002043

ST50511785

T5648_SIGMA

Tamizam

Tamofen

Tamone

Tamoplex (TN)

Tamoxasta

Tamoxen

tamoxifen

Tamoxifen

Tamoxifen (INN)

TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1))

Tamoxifen (TN)

Tamoxifen (Z)

Tamoxifen [INN:BAN]

Tamoxifen and its salts

Tamoxifen citrate

Tamoxifen Citrate

Tamoxifene

Tamoxifène

Tamoxifene [INN-French]

Tamoxifeno

Tamoxifeno [INN-Spanish]

Tamoxifenum

Tamoxifenum [INN-Latin]

Tocris-0999

Tomaxithen

TRANS FORM OF TAMOXIFEN

trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine

trans-Tamoxifen

Trans-Tamoxifen

UNII-094ZI81Y45

UPCMLD-DP027

Valodex

Zemide

Zitazonium

Selective Estrogen Receptor Modulators

Phase 3

Hormone Antagonists

Phase 3

Hormones

Phase 3

Hormones, Hormone Substitutes, and Hormone Antagonists

Phase 3

Estrogen Antagonists

Phase 3

Estrogen Receptor Modulators

Phase 3

Estrogens

Phase 3

Bone Density Conservation Agents

Phase 3

Antineoplastic Agents, Hormonal

Phase 3

Menthol

Approved

Not Applicable

2216-51-5

16666

Synonyms:

(&#8722

(-)-(1R,3R,4S)-Menthol

(-)-menthol

()-Menthol

(-)-Menthyl alcohol

(-)-p-Menthan-3-ol

(-)-trans-p-Menthan-cis-ol

(-)-trans-P-Menthan-cis-ol

(+-)-(1R*,3R*,4S*)-Menthol

(+-)-Menthol

(+)-Neo-menthol

(+)-p-Menthan-3-ol

(+/-)-Menthol

(+/-)-p-Menthan-3-ol

(1a,2b,5a)-5-Methyl-2(1-methylethyl)cyclohexanol

(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol

(1R-(1-a,2-b,5-a))-5-Methyl-2-(1-methylethyl)cyclohexanol

(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol

(1R-(1-α,2-β,5-α))-5-methyl-2-(1-methylethyl)cyclohexanol

(1R)-(-)-Menthol

(1r,2s,5r)-(-)-menthol

(1R,2S,5R)-(-)-Menthol

(1R,2S,5R)-Menthol

(1R,3R,4S)-(-)-Menthol

(1R,3R,4S)-(-)-MENTHOL

(1S, 2S, 5R)-(+)-Neomenthol

(1S,2R,5R)-(+)-Isomenthol

(1S,2R,5S)-(+)-Menthol

(1S,2R,5S)-Menthol

(1α,2β,5α)-5-methyl-2(1-methylethyl)cyclohexanol

(L)-MENTHOL

(r)-(-)-menthol

(R)-(-)-Menthol

)-Menthol

1490-04-6

15356-60-2

15356-70-4

15785_RIEDEL

15785_SIAL

19863P

1-Menthol

20747-49-3

2216-51-5

2-Isopropyl-5-methylcyclohexanol

3-p-Menthol

491-02-1

4-Isopropyl-1-methylcyclohexan-3-ol

551376_ALDRICH

551376_FLUKA

588733_ALDRICH

5-Methyl-2-(1-methylethyl)cyclohexanol

5-Methyl-2-(1-methylethyl)-cyclohexanol

5-methyl-2-(propan-2-yl)cyclohexanol

5-methyl-2-propan-2-ylcyclohexan-1-ol

5-Methyl-2-propan-2-ylcyclohexan-1-ol

613290_ALDRICH

613290_FLUKA

63660_FLUKA

63670_ALDRICH

63670_FLUKA

63975-60-0

6C6A4A8C-A054-468C-A1F0-F29E39838CF2

89-78-1

98167-53-4

AC1L1B2E

AC1L28FR

AC1Q1NQ2

AC1Q2QQM

AI3-08161

AI3-52408

AKOS000119740

AR-1J3337

BB_NC-0057

BRN 1902288

BRN 3194263

BSPBio_003062

C00400

C10H20O

Caswell No. 540

CCRIS 3728

CCRIS 375

CCRIS 4666

CCRIS 9231

CHEBI:15409

CHEBI:545611

CHEMBL256087

CHEMBL470670

CID1254

CID16666

cis-1 ,3-trans-1,4-(+-)-menthol

cis-1,3-trans-1,4-(+-)-menthol

D-(-)-Menthol

d,l-Menthol

D00064

D008610

D04849

D04918

DB00825

DivK1c_000820

dl-3-p-Menthanol

dl-Menthol

dl-Menthol (JP15)

d-Menthol

d-Neomenthol

D-p-Menthan-3-ol

EINECS 201-939-0

EINECS 207-724-8

EINECS 216-074-4

EINECS 218-690-9

EINECS 239-387-8

EINECS 239-388-3

EPA Pesticide Chemical Code 051601

FEMA No. 2665

Fisherman's friend lozenges

Fisherman's friend lozenges (TN)

Headache crystals

Hexahydrothymol

HMS1922G13

HMS2092L14

HMS502I22

HSDB 5662

HSDB 593

I06-1216

I14-7371

IDI1_000820

KBio1_000820

KBio2_000785

KBio2_003353

KBio2_005921

KBio3_002562

KBioSS_000785

Kerasal

l-(-)-Menthol

L-(-)-menthol

L-(-)-Menthol

Levomenthol

Levomenthol [INN:BAN]

Levomentholum

Levomentholum [INN-Latin]

Levomentol

l-Menthol

L-menthol

L-Menthol

l-Menthol (JP15)

l-Menthol (natural)

l-Menthol (TN)

LMPR0102090001

LS-2353

LS-57201

LS-886

LS-89531

LS-89533

M0321

M0545

M2772_SIAL

Menthacamphor

MENTHOL

--MENTHOL

Menthol (USP)

Menthol (VAN)

Menthol natural

Menthol natural, brazilian

Menthol racemic

Menthol racemique

Menthol racemique [French]

Menthol solution

Menthol, (1alpha,2beta,5alpha)-isomer

Menthol, (1alpha,2beta,5alpha)-Isomer

Menthomenthol

Menthyl alcohol

MLS002207256

MolPort-000-849-729

MolPort-001-793-392

NCGC00159382-02

NCGC00159382-03

NCGC00164247-01

NCGC00164247-02

nchembio862-comp1

NCI-C50000

Neoisomenthol

NINDS_000820

NOOLISFMXDJSKH-KXUCPTDWBX

NSC 2603

NSC 62788

NSC2603

NSC62788

Peppermint camphor

p-Menthan-3-ol

P-Menthan-3-ol

Racementhol

Racementhol [INN:BAN]

Racementholum

Racementholum [INN-Latin]

Racementol

Racementol [INN-Spanish]

Racemic menthol

RACEMIC MENTHOL U.S.P.

rac-Menthol

Robitussin Cough Drops

SDCCGMLS-0066659.P001

SMR001306785

SPBio_000869

Spectrum_000305

SPECTRUM1503134

Spectrum2_000855

Spectrum3_001561

Spectrum5_001060

STK802468

Tra-kill tracheal mite killer

U.S.p. menthol

U.S.P. Menthol

UNII-BZ1R15MTK7

UNII-L7T10EIP3A

UNII-YS08XHA860

W266507_ALDRICH

W266523_ALDRICH

W266590_ALDRICH

WLN: L6TJ AY1&1 BQ D1

WLN: L6TJ AY1&1 DQ D1 -L

ZINC01482164

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia	Active, not recruiting	NCT01357772	Phase 3	Tamoxifen;placebo
2	Energy Balance and Breast Cancer Aspects-II	Recruiting	NCT02240836	Not Applicable

Search NIH Clinical Center for Comedo Carcinoma

Sources

Genetic Tests for Comedo Carcinoma

Sources

Anatomical Context for Comedo Carcinoma

MalaCards organs/tissues related to Comedo Carcinoma:

⁴¹

Breast, Bone

Sources

Publications for Comedo Carcinoma

Articles related to Comedo Carcinoma:

#	Title	Authors	Year
1	Surface topography and ultrastructure correlation between human breast infiltrating ductal carcinoma of non special type and coexisting human breast infiltrating ductal carcinoma of non special type with in situ comedo carcinoma. ( 17472243 )	Voloudakis G.E....Voloudakis-Baltatzis I.E.	2003
2	Ultrastructure of the periductal area of comedo carcinoma in situ of the breast. ( 11508833 )	Tang P....Hajdu S.I.	2001

Sources

Genes for Comedo Carcinoma

Genes related to Comedo Carcinoma (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	ERBB2	Erb-B2 Receptor Tyrosine Kinase 2	Protein Coding	15.24	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
2	HNMT	Histamine N-Methyltransferase	Protein Coding	14.58	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
3	HNRNPA1	Heterogeneous Nuclear Ribonucleoprotein A1	Protein Coding	14.38	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
4	NDUFS3	NADH:Ubiquinone Oxidoreductase Core Subunit S3	Protein Coding	14.25	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
5	ESR1	Estrogen Receptor 1	Protein Coding	14.17	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
6	NDUFS4	NADH:Ubiquinone Oxidoreductase Subunit S4	Protein Coding	14.04	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)

Sources

Variations for Comedo Carcinoma

Cosmic variations for Comedo Carcinoma:

⁹

(show all 44)

#	Cosmic Mut ID	Gene Symbol	COSMIC Disease Classification (Primary site, Site subtype, Primary histology, Histology subtype)	Mutation CDS	Mutation AA	GRCh38 Location	Conf
1	COSM6005476	ZFHX3	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.2403A>T	p.K801N	16:72957743-72957743	5
2	COSM10656	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.742C>T	p.R248W	17:7674221-7674221	5
3	COSM43559	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.517G>T	p.V173L	17:7675095-7675095	5
4	COSM10701	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.824G>T	p.C275F	17:7673796-7673796	5
5	COSM10867	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.797G>A	p.G266E	17:7673823-7673823	5
6	COSM44415	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.711G>C	p.M237I	17:7674252-7674252	5
7	COSM44737	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.860A>G	p.E287G	17:7673760-7673760	5
8	COSM6932	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.733G>A	p.G245S	17:7674230-7674230	5
9	COSM10662	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.743G>A	p.R248Q	17:7674220-7674220	5
10	COSM10779	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.818G>T	p.R273L	17:7673802-7673802	5
11	COSM43714	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.836G>A	p.G279E	17:7673784-7673784	5
12	COSM44901	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.532C>G	p.H178D	17:7675080-7675080	5
13	COSM10660	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.818G>A	p.R273H	17:7673802-7673802	5
14	COSM43814	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.587G>C	p.R196P	17:7674944-7674944	5
15	COSM11089	TP53	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.584T>C	p.I195T	17:7674947-7674947	5
16	COSM6906973	SMARCA4	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.1111G>T	p.E371*	19:10987917-10987917	5
17	COSM6906974	PPP2R1A	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.510C>A	p.F170L	19:52212692-52212692	5
18	COSM775	PIK3CA	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.3140A>G	p.H1047R	3:179234297-179234297	5
19	COSM12458	PIK3CA	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.1634A>C	p.E545A	3:179218304-179218304	5
20	COSM776	PIK3CA	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.3140A>T	p.H1047L	3:179234297-179234297	5
21	COSM760	PIK3CA	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.1624G>A	p.E542K	3:179218294-179218294	5
22	COSM774	PIK3CA	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.3139C>T	p.H1047Y	3:179234296-179234296	5
23	COSM763	PIK3CA	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.1633G>A	p.E545K	3:179218303-179218303	5
24	COSM754	PIK3CA	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.1035T>A	p.N345K	3:179203765-179203765	5
25	COSM580	NRAS	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.181C>A	p.Q61K	1:114713909-114713909	5
26	COSM565	NRAS	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.35G>C	p.G12A	1:114716126-114716126	5
27	COSM6057047	NOTCH1	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.7372C>T	p.P2458S	9:136496367-136496367	5
28	COSM6005481	MAP2K2	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.931G>T	p.D311Y	19:4097332-4097332	5
29	COSM521	KRAS	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.35G>A	p.G12D	12:25245350-25245350	5
30	COSM532	KRAS	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.38G>A	p.G13D	12:25245347-25245347	5
31	COSM516	KRAS	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.34G>T	p.G12C	12:25245351-25245351	5
32	COSM520	KRAS	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.35G>T	p.G12V	12:25245350-25245350	5
33	COSM1179671	KMT2C	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.925C>T	p.P309S	7:152273792-152273792	5
34	COSM4595028	KMT2C	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.2681G>A	p.R894Q	7:152235905-152235905	5
35	COSM6057048	HRAS	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.148A>G	p.T50A	11:533908-533908	5
36	COSM6906971	H3F3A	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.218G>A	p.R73Q	1:226065745-226065745	5
37	COSM48358	ERBB2	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.929C>T	p.S310F	17:39711955-39711955	5
38	COSM14060	ERBB2	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.2264T>C	p.L755S	17:39723967-39723967	5
39	COSM19786	CDH1	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.779C>T	p.P260L	16:68810288-68810288	5
40	COSM6057049	AKT1	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.61A>G	p.T21A	14:104780202-104780202	5
41	COSM33765	AKT1	breast,NS,carcinoma in situ,ductal carcinoma in situ	c.49G>A	p.E17K	14:104780214-104780214	5
42	COSM5174142		breast,NS,carcinoma in situ,ductal carcinoma in situ	c.884C>T	p.S295F	17:39711955-39711955	5
43	COSM6906972		breast,NS,carcinoma in situ,ductal carcinoma in situ	c.1111G>T	p.E371*	19:10987917-10987917	5
44	COSM6964823		breast,NS,carcinoma in situ,ductal carcinoma in situ	c.659C>T	p.T220M	1:39897898-39897898	5

Sources

Expression for Comedo Carcinoma

Search GEO for disease gene expression data for Comedo Carcinoma.

Sources

Pathways for Comedo Carcinoma

Pathways related to Comedo Carcinoma according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	Signaling by ERBB4 ⁶⁶ Show member pathways Downregulation of ERBB4 signaling ⁶⁶ ErbB4 signaling events ¹ Nuclear signaling by ERBB4 ⁶⁶	10.99	ERBB2 ESR1
2	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors ⁶⁶ Show member pathways Activation of the TFAP2 (AP-2) family of transcription factors ⁶⁶ Negative regulation of activity of TFAP2 (AP-2) family transcription factors ⁶⁶ TFAP2 (AP-2) family regulates transcription of cell cycle factors ⁶⁶ TFAP2 (AP-2) family regulates transcription of growth factors and their receptors ⁶⁶ TFAP2 (AP-2) family regulates transcription of other transcription factors ⁶⁶ TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation ⁶⁶	10.59	ERBB2 ESR1

Sources

GO Terms for Comedo Carcinoma

Cellular components related to Comedo Carcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	respiratory chain	GO:0070469	8.96	NDUFS3 NDUFS4
2	mitochondrial respiratory chain complex I	GO:0005747	8.62	NDUFS3 NDUFS4

Biological processes related to Comedo Carcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	phosphatidylinositol phosphorylation	GO:0046854	9.37	ERBB2 ESR1
2	mitochondrial respiratory chain complex I assembly	GO:0032981	9.32	NDUFS3 NDUFS4
3	positive regulation of fibroblast proliferation	GO:0048146	9.26	ESR1 NDUFS4
4	mitochondrial electron transport, NADH to ubiquinone	GO:0006120	9.16	NDUFS3 NDUFS4
5	reactive oxygen species metabolic process	GO:0072593	8.96	NDUFS3 NDUFS4
6	cellular respiration	GO:0045333	8.62	NDUFS3 NDUFS4

Molecular functions related to Comedo Carcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	GO:0046934	9.16	ERBB2 ESR1
2	NADH dehydrogenase (ubiquinone) activity	GO:0008137	8.96	NDUFS3 NDUFS4
3	oxidoreductase activity, acting on NAD(P)H	GO:0016651	8.62	NDUFS3 NDUFS4

Sources

Sources for Comedo Carcinoma

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia